Showing results (11-20 of 372) with videos related to
Sort By:
Pageof 38
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: TG-1031, Transgene SAC Doehn, D JochamCurrent Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: CN-706, Calydon IncC Doehn, D JochamDer Urologe. Ausg. A|January 5, 2002
[Locally advanced or metastatic bladder carcinoma. Current aspects of therapy]H Rübben, T OttoDer Urologe. Ausg. A|January 1, 1981
[Clinical analysis of the indication for lymphangiography in urological tumor patients (author's transl)]H Rübben, W LutzeyerDer Urologe. Ausg. A|May 1, 1993
[Is risk-oriented therapy in stage I non-seminoma tumor advisable?]S Krege, H RübbenCurrent Opinion in Molecular Therapeutics|May 8, 2001
Technology evaluation: CV-787, Calydon IncC Doehn, D JochamAktuelle Urologie|May 18, 2004
[Immunotherapy of renal cell carcinoma: results from current phase-III-trials]C Doehn, D JochamUrologia Internationalis|January 1, 1996
Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinomaP Fornara, D JochamPageof 38